Patent · US Active

Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases

US8802858B2 · kind B2 · utility

5Cited by

1References

20Claims

0Family size

Assignee

Basilea Pharmaceutica AG · CH

Inventors

Jens Pohlmann · Basel, CH
Felix Bachmann · Basel, CH

Key dates

Filing date	Jul 26, 2010
Grant date	Aug 12, 2014
Priority date	—
Expiry date	Oct 16, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula IIin which Z is C or N and the Z ring is optionally further substituted; R1 is H, lower alkylcarbonyl, hydroxy-lower alkyl or cyano-lower alkyl; and R2 is a group selected from (b), (c), and (d):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.